MedPath

Importance of continuous oxygen monitoring during the six-minute walk test in patients with chronic respiratory diseases

Recruiting
Conditions
Asthma
Chronic obstructive pulmonary disease
D012140
Other interstitial lung diseases with fibrosis
Pulmonary Hypertension
Registration Number
RBR-9qss9jn
Lead Sponsor
Hospital de Clinicas de Porto Alegre (HCPA)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Individuals of both genders; over 18 years of age; with chronic respiratory disease; who have a request from the assistant physician to perform the six-minute walk test at the Pulmonary Physiology Unit of the Hospital de Clinicas de Porto Alegre (HCPA)

Exclusion Criteria

Individuals with contraindications for performing the six-minute walk test; those who performed at least one six-minute walk test in the 3 months prior to inclusion; which weather conditions that standard pulse oximetry signal in the resting measurement at the beginning of the six-minute walk test

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate the difference in the distance walked between the six-minute walk test (6MWT) with and without continuous monitoring of peripheral oxygen saturation (SpO2) in patients with chronic respiratory diseases, using the 6MWT method, which are not the requirements with respiratory disease chronic disease will be randomized to one of the protocols: A) WITH continuous monitoring of SpO2, or B) WITHOUT continuous monitoring of SpO2. In order to have the statistical power to detect a difference of 30 meter with standard deviation 90 meters between the tests performed with and without continuous SpO2 monitoring, it intends to include a minimum sample of 143 participants in each group. Anticipating possible losses and unsatisfactory collections, we planned the final inclusion of 300 participants. So we will observe if there is a difference in the distance covered in the 6MWT between the groups
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath